Xingying Zhang

2 ta ish

Chinese Academy of Sciences

1. Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors

   Zhenguang Wang, Na Li, Kaichao Feng +14

   MaqolaOAOchiq kirish20213 iqtibos

   ABIABI:AkademIndex/2026.other.102893

2. TGF-β inhibition via CRISPR promotes the long-term efficacy of CAR T cells against solid tumors

   Na Tang, Chen Cheng, Xingying Zhang +6

   Maqola20203 iqtibos

   ABIABI:AkademIndex/2026.other.296864